Long Term Follow-up of HPV Vaccine in HIV (CTN 236)

CompletedOBSERVATIONAL
Enrollment

241

Participants

Timeline

Start Date

June 1, 2015

Primary Completion Date

March 30, 2021

Study Completion Date

March 30, 2021

Conditions
Cervical CancerHuman Papillomavirus InfectionHuman Immunodeficiency VirusCervical DysplasiaGenital Warts
Trial Locations (13)

V6H 3N1

Oak Tree Clinic, BC Women's Hospital & Health Centre, Vancouver

V6Z 1Y6

AIDS Research Program & the John Ruedy Immunodeficience Clinic, St. Paul's Hospital, Vancouver

L8S 1A4

Hamilton Health Sciences, Hamilton

K7L 5G2

Infection & Immunology Clinic, Hotel Dieu, Kingston

K1H 8L1

Children's Hospital of Eastern Ontario (CHEO), Ottawa

M5C 1K2

St. Michael's Hospital, Toronto

M5G 1X8

The Hospital for Sick Children, Toronto

M5G 2N2

Maple Leaf Research, Toronto

Toronto General Hospital, Toronto

N8W 1E3

HIV Care Program, Windsor

H3T 1C5

Centre de maternal et infantile sur le sida, CHU Sainte Justine, Montreal

H4A 3J1

Chronic Viral Illness Service, Hopital Royal Victoria (McGill University), Montreal

G1V 4G2

CHUL and Mother-Child Center Soleil, Centre de Recherche en Infectiologie CHU de Quebec, (Universite Laval), Québec

All Listed Sponsors
collaborator

CIHR Canadian HIV Trials Network

NETWORK

collaborator

Women's Health Research Institute of British Columbia

OTHER

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

BC Women's Hospital & Health Centre

OTHER

collaborator

Merck Canada Inc.

INDUSTRY

collaborator

University Health Network, Toronto

OTHER

collaborator

McGill University

OTHER

collaborator

University of Saskatoon

UNKNOWN

collaborator

British Columbia Centre for Disease Control

OTHER_GOV

collaborator

Vaccine Evaluation Center, Canada

OTHER

collaborator

British Columbia Cancer Agency

OTHER

lead

University of British Columbia

OTHER

NCT06915779 - Long Term Follow-up of HPV Vaccine in HIV (CTN 236) | Biotech Hunter | Biotech Hunter